Vnitr Lek 2005, 51(11):1232-1235

Diabetes mellitus 1. typu a autoimunita - editorial

J. Vavřinec
Pediatrická klinika 2. lékařské fakulty UK a FN Motol, Praha, přednosta prof. MUDr. Jan Vavřinec, DrSc.

Received: March 7, 2005; Published: November 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vavřinec J. Diabetes mellitus 1. typu a autoimunita - editorial. Vnitr Lek. 2005;51(11):1232-1235.
Download citation

References

  1. Bennett ST, Lucassen AM, Gough SC et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-292. Go to original source... Go to PubMed...
  2. Dorman JS, La Porte RE, Stone RA et al. Worldwide differences in the incidences of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ β chain. Proc Natl Acad Sci 1990; 87: 7370-7374. Go to original source... Go to PubMed...
  3. Gutierrez-Lopez MD, Bertera S, Chartres MT et al. Susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DAα Arg 52 and HLA-DQβ non-Asp 57 alleles. Diabetologia 1992; 35: 583-588. Go to original source... Go to PubMed...
  4. Libman I, Songer T, LaPorte R. How many people in the U.S. have IDDM? Diabetes Care 1993; 16: 841-842. Go to original source... Go to PubMed...
  5. Lucassen AM, Julier C et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 1993; 4: 305-310. Go to original source... Go to PubMed...
  6. Metcalfe KA, Hitman GA, Fennessy MJ et al. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. Diabetologia 1995; 38: 1223-1229. Go to original source... Go to PubMed...
  7. Miceli D, Zeller M, Dogra R. Insulin gene expression and imprinting in pancreas and lymphoid organs. Diabetes 1999; 48(Suppl 1): A 824. Go to PubMed...
  8. Mijovic CH, Jenkins D, Jacobs KH et al. HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes 1991; 40: 748-753. Go to original source... Go to PubMed...
  9. Morel PA, Dorman JS, Todd JA et al. Aspartic acid at position 57 of the HLA-DQ beta chain protects against Type 1 diabetes. Proc Natl Acad Sci 1988; 85: 8111-8116. Go to original source... Go to PubMed...
  10. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197. Go to original source... Go to PubMed...
  11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22: 5-19. Go to original source...
  12. Rewers M. The changing face of the epidemiology of insulin-dependent diabetes mellitus (IDDM): Research designs and models of disease causation. Ann Med 1991; 23: 419-426. Go to original source... Go to PubMed...
  13. Rewers M, Norris J, Dabelea D. Epidemiology of type I diabetes. In: Eisenbarth GS. Type I diabetes: Molecular, cellular, and clinical immunology. Barbara Davis Center for Childhood Diabetes, Online Edition Version, Second Edition 2004: 56-87.
  14. Rönningen K, Spurkland A. HLA class II associations in insulin-dependent diabetes mellitus among black, Caucasoids and Japanese. In: Tsuji K, Aizawa H. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press 1993: 713-722.
  15. Undlien DE, Friede T et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149. Go to original source... Go to PubMed...
  16. Vavřinec J, Cinek O. Autoimunitní inzulitida a diabetes mellitus 1. typu. In: Perušičová J. Trendy soudobé diabetologie. Praha: Galén 2000; 4: 129-158.
  17. Vavřinec J, Cinek O, Šumník Z. Genetické a imunologické aspekty diabetu I. typu v dětském věku. Čes Slov Pediat 2000; 55: 707-711.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.